Abstract Sudden death in young competitive athletes can be avoided by implementation of pre-participation screening programmes. A screening programme should be performed only by trained physicians and should include the athlete's personal and family history, physical examination results, and the readings from a 12-leadelectrocardiogram. The athlete should undergo this screening programme every second year to detect progressive diseases. In addition, the programme should include detailed instructions to the athletes to pause training during infections in order to prevent sudden death due to myocarditis. dramatic event with an incidence <1-3/100,000 athletes.
S UDDEN DEATH IN YOUNG ATHLETES IS A RARE BUT
dramatic event with an incidence <1-3/100,000 athletes. [1] [2] [3] These deaths are mainly caused by cardiovascular diseases, with cardiomyopathies and coronary anomalies being the leading causes [2] [3] [4] ( Fig 1) . Corrado et al demonstrated that the early identification of cardiovascular diseases through a nationwide screening programme could prevent athletes from suffering sudden cardiac death. Screening could lead to a decrease of 89% in such deaths 6 ( Fig 2) . Screening programmes are recommended by several medical and sports associations, such as the European Society of Cardiology, the American Heart Association, the International Olympic Committee, and the American Society for Sports Medicine. 5, [7] [8] [9] No international paediatric society, however, appears to have made any recommendations in this regard. Although screening programmes are universally recommended, the protocols are not uniform: the difference in most programmes being the inclusion or not of 12-lead electrocardiogram screening. The major concerns against electrocardiogram screening are the additional costs and the number of false-positive results. 5 The implementation of electrocardiogram guidelines by Corrado et al 10 and Drezner et al 11 , and special training for the physicians involved, has led to a reduction in the number of false-positive results. 12 Underlining the importance of a standardised screening programme by trained physicians, Thünenkötter et al performed pre-participation examinations in all athletes of the FIFA World Cup 2006, and demonstrated that 1% of these athletes, who play in the best leagues all over the world, had findings indicating the presence of cardiovascular diseases.
European Society of Cardiology, 7 with special focus on the necessity for a 12-lead electrocardiogram to facilitate the timely detection of cardiovascular abnormalities in young athletes. This could result in proper diagnosis and therapy after detection, and reduce the risk for sudden cardiac death. The study, moreover, wishes to emphasise the importance of proper patient education to prevent sudden cardiac death due to myocarditis (Fig 3) .
Causes of sudden cardiac death
Maron et al 3 investigated the sudden death of 1866 athletes in North America. Of this total, 56% of the deaths were due to cardiovascular diseases, 22% due to blunt trauma, 3% due to commotio cordis, and 10% due to miscellaneous causes. The leading cause of sudden cardiac death in this study was hypertrophic cardiomyopathy, as seen in 36% of the athletes, followed by coronary anomalies (17%), myocarditis (6%), and arrhythmogenic right-ventricular cardiomyopathy and mitral valve prolapse (4%) (Fig 1) .
After the implementation of a nationwide screening programme in Italy, the leading cause of sudden cardiac death was arrhythmogenic right-ventricular cardiomyopathy, which was seen in 22% of those surveyed. Hypertrophic cardiomyopathy as a cause of sudden cardiac death was found in 2% of the athletes, whereas the incidence of hypertrophic cardiomyopathy in non-athletes who were not screened was 9.5%. This discrepancy is explained by the unique exposure of Italian athletes to this systemic cardiovascular screening programme. 4, 6 Table 1 shows the causes of sudden cardiac death after the implementation of the screening programme in screened athletes and unscreened non-athletes.
It is very important to note that some diseases can show a negative history and absent symptoms on physical examination in children. In particular, progressive diseases such as arrhythmogenic right-ventricular cardiomyopathy, usually starting during late adolescence, and heterogeneous diseases such as mitral-valve prolapse, which can appear in mild-to-severe forms, often have no symptoms in children, emphasising the importance of follow-up examinations. 14, 15 It is not the purpose of this paper to discuss the necessity of screening the entire population aged 12-25 years for cardiovascular disease, as this might not be as effective as screening in young competitive athletes alone. 16 
Recommendations for a cardiovascular screening programme
Nearly all cardiological and sports associations recommend that a screening programme should include a family and personal history and a physical examination, but they continue to challenge the need for a routine 12-lead electrocardiogram. 5, 7, 8 The screening should be performed on athletes when they start their competitive activity, and should be repeated routinely every 1-3 years. 7, 9, 14, 15 A great number of conditions causing sudden cardiac death are genetically determined, indicating the importance of family history. According to the guidelines of the European Society of Cardiology, athletes are considered to be at risk for sudden cardiac death when their close relatives had experienced a premature heart attack or a sudden cardiac death (<55 years of age in men, <65 years in women). 7, 16 The presence of a disabling cardiovascular disease, such as cardiomyopathy, Marfan Syndrome, long QT syndrome, Brugada Syndrome, severe arrhythmia, or coronary artery disease, is also indicative of being at Vol. 27, No. 9
Fritsch et al: Cardiovascular pre-participation screening in young athletes risk. Personal history is considered positive in case of a family history of exertional chest pain, syncope or near-syncope, irregular heartbeat or palpitations, unexplained shortness of breath, or fatigue during exercise. 5, 7, 16 Physical examination is considered positive if a heart murmur -any diastolic and systolic grade >2/6, midor end-systolic click, second single or widely split or fixed heart sound -is detected. A diminished or delayed femoral pulse, an irregular heart rhythm, or Couplets, triplets and non-sustained ventricular tachycardia
Borderline ECG findings in athletes
These ECG findings in isolation likely do not represent pathological cardiovascular disease in athletes, but the presence of two or more borderline ndings may warrant additional investigation until further data become available.
ECG abnormality definition Left axis deviation
−30°to −90°L eft atrial enlargement Prolonged P wave duration of > 120 ms in leads I or II with negative portion of the P wave ≥ 1 mm in depth and ≥ 40 ms in duration in lead V1 Right axis deviation > 120°R ight atrial enlargement P wave ≥ 2.5 mm in II, III or aVF Complete right bundle branch block rSR' pattern in lead V1 and an S wave wider than R wave in lead V6 with QRS duration ≥ 120 ms
normal ECG findings in athletes
These training-related ECG alterations are physiological adaptations to regular exercise, considered normal variants in athletes and do not require further evaluation in asymptomatic athletes with no signi cant family history.
normal ECG finding definition Increased QRS voltage
Isolated QRS voltage criteria for left (SV1 + RV5 or RV6 > 3.5 mV) or right ventricular hypertrophy (RV1 + SV5 or SV6 > 1.1 mV) Incomplete right bundle branch block rSR' pattern in lead V1 and a qRS pattern in lead V6 with QRS duration < 120 ms Early repolarisation J point elevation, ST elevation, J waves or terminal QRS slurring in the inferior and/or lateral leads Black athlete repolarisation variant J-point elevation and convex ('domed') ST segment elevation followed by T wave inversion in leads V1-V4 in black athletes Juvenile T wave pattern T wave inversion V1-V3 in athletes less than age less than 16 Sinus bradycardia ≥ 30 bpm Sinus arrhythmia Heart rate variation with respiration: rate increases during inspiration and decreases during expiration Ectopic atrial rhythm P waves are a different morphology compared with the sinus P wave, such as negative P waves in the inferior leads ('low atrial rhythm') Junctional escape rhythm QRS rate is faster than the resting P wave or sinus rate and typically less than 100 beats/min with narrow QRS complex unless the baseline QRS is conducted with aberrancy 1°atrioventricular block PR interval 200-400 ms Mobitz type I (Wenckebach) 2°a trioventricular block PR interval progressively lengthens until there is a non-conducted P wave with no QRS complex; the rst PR interval after the dropped beat is shorter than the last conducted PR interval elevated blood pressure readings over the 95th percentile also indicate positive risk. 5, 7, 16, 17 Other positive findings may be musculoskeletal or ocular abnormalities suggestive of Marfan Syndrome. 7, 16 The American Heart Association still recommends a screening programme that includes only personal and family history and physical examinations. 5 In contrast, the European Society of Cardiology, the International Olympic Committee, several European countries, and several professional sporting leagues recommend cardiovascular pre-participation screening including a 12-lead-electrogradiogram. 7, 8 This procedure enhances the probability of detecting cardiovascular diseases in athletes. 10, 12, 18 The most common concern regarding the electrocardiogram is the high incidence of a false-positive reading, which can result in further cardiovascular evaluation or restriction from sport. 5 After the recommendation of interpretation criteria for a 12-lead electrocardiogram by Corrado et al, the proportion of abnormal electrocardiogram readings decreased from 16 to 9%. 10, 19 These criteria have recently been revised by an international committee 20 ( Table 2 ). Electrocardiogram patterns in hypertrophic cardiomyopathy are shown in up to 95% of the patients studied. 21 The nationwide screening programme in Italy that included a 12-lead electrocardiogram resulted in a significant reduction of sudden cardiac death, showing a 77% higher sensitivity for detecting hypertrophic cardiomyopathy than history or physical examination. 6 Drezner et al showed an improvement in electrocardiogram interpretations by primary care and cardiology physicians from a baseline of 74/85%-91/ 96% after they used an electrocardiogram interpretation tool. 12 Asif et al summarised in their reviews that the cost-effectiveness of a screening programme that includes an electrocardiogram cannot be doubted 18, 22 (Table 3) . Pre-participation examination should be performed by doctors trained in examining athletes and in reading their electrocardiogram.
An important part of a screening programme is the importance of reducing the incidence of sudden cardiac death due to myocarditis: the risk for sudden cardiac death due to myocarditis is about 6-12%. 3, 6, 23 It is important to note that the clinical presentation of myocarditis with an asymptomatic course up to sudden cardiac death complicates both diagnosis and prevention. Weber et al showed that, in myocarditis, the risk for sudden cardiac death does not correlate with the intensity of inflammation. 24 In addition, exercise in patients suffering from myocarditis enhances the viral disease, worsens cardiomyopathy, and aggravates the autoimmune process against the heart tissue. 25, 26 The best method of prevention would be a detailed education of young athletes during the pre-participation examination, explaining to them the need to pause exercise and competition during an infection to reduce Vol. 27, No. 9
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Conclusion
This manuscript posits that these recommendations are the first by an international paediatric society. The cardiovascular pre-participation screening of young athletes should include personal and family history, physical examination, and a 12-lead electrocardiogram. Trained physicians using the Electrocardiogram Criteria should perform the screening programme. The screening programme should include instructing athletes to suspend exercise during infections and recognise red flag signs. The screening should be performed before the start of competitive sports and should be repeated every second year to detect progressive diseases.
